SEARCH RESULTS

329930 RESULTS

PBT2 Takes a Dive in Phase 2 Alzheimer’s Trial

RESEARCH NEWS 2014-04-01 Research News On March 31, the Australian company Prana Biotechnology announced negative top-line results of its only Phase 2 study of the anti-amyloid drug PBT2. Called IMAGINE, the trial had enrolled 42 people with prodromal or mild Alzheimer’s disease

Debby Tsuang


University of Washington
Seattle, United States

Current Filters

No filters selected

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE